Blinatumomab in Acute Lymphoblastic Leukemia
1 vistas
• 06/15/23
0
0
Empotrar
administrator
Suscriptores
In this segment, Dan Douer, MD, and Mark R Litzow, MD, describe the novel immunotherapy agent, blinatumomab.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios